Cross-platform expression microarray performance in a mouse model of mitochondrial disease therapy

Molecular Genetics and Metabolism

Volumn 99, Issue 3, 2010, Pages 309-318

  Zhang, Zhe ^a   Gasser, David L ^b   Rappaport, Eric F ^a   Falk, Marni J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioinformatics; Metabolic disease; Metabolic pathway profiling

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; RNA; STEROID; UBIQUINONE;

ARTICLE; BIOSYNTHESIS; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; EXON; FEMALE; GENE EXPRESSION PROFILING; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; MALE; METABOLISM; MICROARRAY ANALYSIS; MOLECULAR PROBE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPRODUCIBILITY; RNA HYBRIDIZATION;

ANIMALS; ANTIOXIDANTS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; MICE; MICE, KNOCKOUT; MITOCHONDRIAL DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROBUCOL; PROTEINS; RNA; TREATMENT OUTCOME; UBIQUINONE;

MUS;

EID: 76349111348     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.10.179     Document Type: Article

References (23)

1. Xing Y., Kapur K., and Wong W.H. Probe selection and expression index computation of Affymetrix Exon arrays. PLoS ONE 1 (2006) e88
2. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei N., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., Philips K.L., Pine P.S., Pusztai L., Qian F., Ren H., Rosen M., Rosenzweig B.A., Samaha R.R., Schena M., Schroth G.P., Shchegrova S., Smith D.D., Staedtler F., Su Z., Sun H., Szallasi Z., Tezak Z., Thierry-Mieg D., Thompson K.L., Tikhonova I., Turpaz Y., Vallanat B., Van C., Walker S.J., Wang S.J., Wang Y., Wolfinger R., Wong A., Wu J., Xiao C., Xie Q., Xu J., Yang W., Zhang L., Zhong S., Zong Y., and Slikker Jr. W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24 (2006) 1151-1161
3. Nevins J.R., and Potti A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat. Rev. Genet. 8 (2007) 601-609
4. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., and Chinnaiyan A.M. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 101 (2004) 9309-9314
5. Zhang Z., Chen D., and Fenstermacher D.A. Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome. BMC Genomics 8 (2007) 331
6. McHale C.M., Zhang L., Lan Q., Li G., Hubbard A.E., Forrest M.S., Vermeulen R., Chen J., Shen M., Rappaport S.M., Yin S., Smith M.T., and Rothman N. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. Genomics 93 (2009) 343-349
7. Barnes M., Freudenberg J., Thompson S., Aronow B., and Pavlidis P. Experimental comparison, cross-validation of the Affymetrix, Illumina gene expression analysis platforms. Nucleic Acids Res. 33 (2005) 5914-5923
8. de Reynies A., Geromin D., Cayuela J.M., Petel F., Dessen P., Sigaux F., and Rickman D.S. Comparison of the latest commercial short and long oligonucleotide microarray technologies. BMC Genomics 7 (2006) 51
9. Peng M., Falk M.J., Haase V.H., King R., Polyak E., Selak M., Yudkoff M., Hancock W.W., Meade R., Saiki R., Lunceford A.L., Clarke C.F., and Gasser D.L. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet. 4 (2008) e1000061
10. Hancock W.W., Tsai T.L., Madaio M.P., and Gasser D.L. Cutting edge: multiple autoimmune pathways in kd/kd mice. J. Immunol. 171 (2003) 2778-2781
11. Peng M., Jarett L., Meade R., Madaio M.P., Hancock W.W., George Jr. A.L., Neilson E.G., and Gasser D.L. Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int. 66 (2004) 20-28
12. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., and Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31 (2003) e15
13. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
14. Perez-Iratxeta C., and Andrade M.A. Inconsistencies over time in 5% of NetAffx probe-to-gene annotations. BMC Bioinformatics 6 (2005) 183
15. Harbig J., Sprinkle R., and Enkemann S.A. A sequence-based identification of the genes detected by probesets on the Affymetrix U133 plus 2.0 array. Nucleic Acids Res. 33 (2005) e31
16. Dai M., Wang P., Boyd A.D., Kostov G., Athey B., Jones E.G., Bunney W.E., Myers R.M., Speed T.P., Akil H., Watson S.J., and Meng F. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33 (2005) e175
17. Carter S.L., Eklund A.C., Mecham B.H., Kohane I.S., and Szallasi Z. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics 6 (2005) 107
18. Liu H., Zeeberg B.R., Qu G., Koru A.G., Ferrucci A., Kahn A., Ryan M.C., Nuhanovic A., Munson P.J., Reinhold W.C., Kane D.W., and Weinstein J.N. AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics 23 (2007) 2385-2390
19. Miyamoto S., Chiorini J.A., Urcelay E., and Safer B. Regulation of gene expression for translation initiation factor eIF-2 alpha: importance of the 3′ untranslated region. Biochem. J. 315 Pt. 3 (1996) 791-798
20. Buckley D.B., and Klaassen C.D. Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney. Drug Metab. Dispos. 37 (2009) 834-840
21. Buckley M.M., Goa K.L., Price A.H., and Brogden R.N. Probucol: a reappraisal of its pharmacological properties, therapeutic use in hypercholesterolaemia. Drugs 37 (1989) 761-800
22. Kuzuya M., and Kuzuya F. Probucol as an antioxidant, antiatherogenic drug. Free Radic. Biol. Med. 14 (1993) 67-77
23. Cleveland W.S. LOWESS: a program for smoothing scatterplots by robust locally weighted regression. Am. Stat. 35 (1981) 54